1. Clagett GP, Anderson FAJr, Geerts W et al. Prevention of Venous
Thromboembolism. Chest 1998; 114: 531–60.
2. Hettiarachchi RJ, Smorenburg SM, Ginsberg J et al. Do
heparins do more than just treat thrombosis? The influence of
heparins on cancer spread. Thromb Haemost 1999; 82: 947–52.
3. The Columbus investigators. Low-molecular-weight heparin
in the treatment of patients with venous thromboembolism. The
Columbus Investigators. N Engl J Med 1997; 337: 657–62.
4. Prystowsky JB, Morasch MD, Eskandari MK et al. Prospective
analysis of the incidence of deep venous thrombosis in bariatric
surgery patients. Surgery 2005; 138: 759–63.
5. Lindberg F, Bergqvist D, Rasmussen I. Incidence of thromboembolic
complications after laparoscopic cholecystectomy:
review of the literature. Surg Laparosc Endosc 1997; 7: 324–31.
6. Amaragiri SV, Lees TA. Elastic compression stockings for prevention
of deep vein thrombosis. Cochrane Database Syst Rev 2000; 3: CD001484.
7. Klerk С, Smorenburg S et al. The Effect of Low Molecular
Weight Heparin on Survival in Patients With Advanced Malignancy.
J Clin Oncol 2005; 23: 2130–5.
8. McLeod RS. The risk of thromboembolism in patients undergoing
colorectal surgery. Drugs 1996; 52 (Suppl. 7): 38–41.
9. Collins R, Scrimgeour A, Yusif S, Peto R. Reduction in fatal
pulmonary embolism and venous thrombosis by perioperative
administration of subcutaneous heparin. N Engl J Med 1988; 318: 1162–73.
10. Miehsler W, Reinisch W, Valic E et al. Is inflammatory bowel
disease an independent and disease specific risk factor for
thromboembolism? Gut 2004; 53 (4): 542–8.
11. Pezzuoli G, Neri Serneri GG, Settembrini et al. Effectiveness
and safety of the low-molecular-weight heparin CY 216 in the
prevention of fatal pulmonary embolism and thromboembolic
death in general surgery. A multicentre, double-blind, randomized,
controlled clinical trial versus placebo (STEP). STEP
Study Group. Haemostasis 1990; 20 (suppl. 1): 193–204.
12. Levine M. Treatment of thrombotic disorders in cancer
patients. Haemostasis 1997; 27 (Suppl. 10): 38–43.
13. Geerts WH et al. Prevention of venous thromboembolism.
The Seventh ACCP Conference on Antithrombotic and Thrombolytic
Therapy. CHEST 2004; 126: 338–400.
14. Hull RD, Raskob GE, Hirsh J. Prophylaxis of venous thromboembolism:
an overview. Chest 1986; 89: 374–83.
15. Варданян А.В., Мумладзе Р.Б., Белоусов Д.Ю., Ройтман
Е.В. Клинико-экономический анализ профилактики пос-
леоперационных венозных тромбоэмболических ослож-
нений. Качествен. клин. практика. 2006; 1: 51–63.
16. Torngren S, Rieger A. Prophylaxis of deep venous thrombosis
in colorectal surgery. Dis Colon Rectum 1982; 25: 563–6.
17. Clagett GP, Anderson FAJr, Heit J et al. Prevention of venous
thromboembolism. Chest 1995; 108: 312–34.
18. Wells PS, Lensing AW, Hirsh J. Graduated compression stockings
in the prevention of postoperative venous thromboembolism.
A meta-analysis. Arch Intern Med 1994; 154: 67–72.
19. Wille-J∅rgensen P, Rasmussen MS, Andersen BR, Borly L.
Heparins and mechanical methods for thromboprophylaxis in
colorectal surgery. Cochrane Database Syst Rev 2003; 4: CD001217.
20. Anderson FA, Wheeler HB, Goldberg RJ. A population-based
perspective of the hospital incidence and case fatality rates of
deep vein thrombosis and pulmonary embolism: the Worchester
DVT study. Arch Intern Med 1991; 151: 933–8.
21. Osborne CK. Tamoxifen in the treatment of breast cancer. N
Engl J Med 1998; 339: 1609–18.
22. Jaffer AK, Barsoum WK, Krebs V et al. Duration of anesthesia
and venous thromboembolism after hip and knee arthroplasty.
Mayo Clin Proc 2005; 80: 732–8.
23. Hendolin H, Mattila MA, Poikolainen E. The effect of lumbar
epidural analgesia on the development of deep vein thrombosis
of the legs after open prostatectomy. Acta Chir Scand 1981; 147:425–9.
24. Riber C, Alstrup N, Nymann T et al. Postoperative thromboembolism
after day-case herniorrhaphy. Br J Surg 1996; 83: 420–1.
25. Devur M, Barrett-Connor E. Estrogen replacement therapy
and the risk of venous thrombosis. Am J Med 1992; 92: 275–82.
26. Bergqvist D, Agnelli G, Cohen AT et al. Duration of prophylaxis
against venous thromboembolism with enoxaparin after
surgery for cancer. New Engl J Med 2002; 346: 975–980.